
William Randolph Maddox MD FHRS (He/Him)
Cardiac Electrophysiology
University of Alabama at Birmingham
701 Princeton Ave SWBirmingham, AL 35211
Fax+1 205-934-3950
Overview of Dr. Maddox
Dr. William Maddox, based in Birmingham, AL, is a cardiologist specializing in cardiac electrophysiology. He completed his clinical cardiac electrophysiology fellowship at the University of Alabama Medical Center and has held the position of Medical Director of Electrophysiology Laboratory at University of Alabama Hospital since 2015. His professional experience focuses on cardiac electrophysiology and managing conditions such as atrial fibrillation and ventricular arrhythmias. Dr. Maddox has contributed significantly to the field with various publications, including studies on atrial arrhythmias in COVID-19 patients and economic evaluations of anesthesiology-led services. He has also been involved in several clinical trials concerning catheter ablation systems for treating atrial fibrillation. Recognized for his contributions, he received numerous honors, including being recognized as a Castle Connolly Top Doctor.
Education & Training
University of Alabama Hospital (Birmingham)Fellowship, Clinical Cardiac Electrophysiology, 2011 - 2012
Medical College of GeorgiaFellowship, Cardiovascular Disease, 2008 - 2011
Medical College of GeorgiaResidency, Internal Medicine, 2004 - 2007
Medical College of Georgia at Augusta UniversityClass of 2004
University of GeorgiaBSEd, Exercise & Sport Science, 1998 - 2000
Certifications & Licensure
AL State Medical License 2011 - 2026
GA State Medical License 2007 - 2019
American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- First Place-Resident Research Day Rahn-Peacock GHSU (Georgia Health Sciences University), 2011
- Resident of the Year Georgia Health Sciences, University of Georgia, 2011
- Finalist, Department of Medicine Resident of the Year 2007
Clinical Trials
- Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2012 Oct 01
- Coherex WAVECREST I Left Atrial Appendage Occlusion Study Start of enrollment: 2010 Oct 01
- A Study of the ReCor Medical Paradise System in Clinical Hypertension
Publications & Presentations
PubMed
- 1 citationsEconomic Evaluation of Anesthesiology-Led Cardiac Implantable Electronic Device Service.Ahmed Zaky, Ryan L Melvin, David Benz, James Davies, Vardas Panayotis
Healthcare. 2023-06-27 - 238 citationsUltrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.Michel Azizi, Kintur Sanghvi, Manish Saxena, Philippe Gosse, John P. Reilly
Lancet. 2021-06-26 - 6 citationsAtrial arrhythmia related outcomes in critically ill COVID-19 patients.Chad M. Colon, James G. Barrios, Joe W Chiles, Todd M. Brown, Steven M. Pogwizd
Pacing and Clinical Electrophysiology. 2021-03-18
Journal Articles
- Significant Discrepancy Between Estimated and Actual Longevity in St Jude Medical Implantable Cardioverter-DefibrillatorsDoppalapudi H, Barrios J, Cuellar J, Gannon M, Yamada T, Kumar V, Maddox WR, Plumb V, Brown TM, McElderry HT, J Cardiovasc Electrophysiol, 1/9/2017
- Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation AblationShah RR, Pillai A, Schafer P, Meggo D, McElderry T, Plumb V, Yamada T, Kmar V, Doppalapudi H, Guter A, Pentecost E, Maddox WR, The American Journal of Cardiology, 1/1/2017
- Electronic Medical Record (EMR) Derived Appropriate Inpatient Risk Stratification and Anticoagulant Treatment of Atrial Fibrillation at a Large Academic Medical Center...Deremer C, Johnson M, Berman A, Carroll M, Maddox W, The Journal of Innovations in Cardiac Rhythm Management, 1/1/2016
Abstracts/Posters
- Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation.Shah R, Schafer P, Meggo D, McElderry T, Plumb V, Yamada T, Kumar V, Doppalapudi H, Gunter A, Pentecost E, Maddox W, AF (Atrial Fibrillation) Symposium Conference, 1/1/2017
- The HAS-BLED score as a predictor for mortality in dialysis patients with atrial fibrillation: challenges and an opportunity for future study.Wong J, Waller J, Diamond M, Bushik S, Sayed A, Kheda M, Nahman NS Jr, Sorrentino RA, Maddox WR, J Invest Med, S AFMR (Southern American Federation for Medical Research), 1/1/2016
- Early mortality in dialysis patients anticoagulated for atrial fibrillation.Bushik S, Waller J, Elmer R, Sorrentino R, Kheda M, Maddox W, Nahman S, Diamond M, J Amer Soc Nephrol, American Society of Nephrology, 1/1/2015
Professional Memberships
- Member
- Fellow
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Georgia Blue Choice HMO
BCBS Georgia BlueChoice Option POS
CIGNA HMO
CIGNA Open AccessCIGNA PPO
Great West PPO
Health Net HMO - Employer Group
Horizon BCBS PPO
Humana ChoiceCare Network PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









